Giving people with cervical cancer a short course of chemotherapy before radiation therapy dramatically improves survival according to the results of a new clinical trial. The data published in ...
Cervical cancer, a key cause of cancer-related deaths among Indian women, can be prevented and cured through early screening and vaccination. India records 123,000 new cases and over 77,000 deaths ...
Cervical cancer patients were significantly more likely to be alive and cancer-free after five years when given a short course of chemotherapy prior to chemoradiation. This is the finding of a ...
REALLY APPRECIATE IT. I WANT TO DIVE RIGHT IN. TALK A LITTLE BIT ABOUT CERVICAL CANCER. WHO IS IMPACTED THE MOST WHEN YOU TALK ABOUT CERVICAL CANCER? WELL, IN ALL IN ALL HONESTY, NOBODY SHOULD BE ...
In Fiji, Ministry of Health official Rachel Devi will coordinate the rollout of the donation funding to cervical cancer programs. Ms Devi, who manages the reproductive, maternal, newborn ...
Adding a six-week course of chemotherapy to the standard course of treatment for locally advanced cervical cancer resulted in a significant increase in survival rates, a new study shows.
A new cervical cancer treatment cuts the risk of death by 40% according to a large-scale study. Researchers at UCL and its associated hospital, University College London Hospital, spent 10 years ...
The World Cancer Congress has concluded in Geneva, Switzerland, with a robust set of recommendations which, if implemented, could contribute to eliminating cervical cancer, which claims nearly 10 ...
JOHANNESBURG - Cervical cancer is still a significant health concern globally, as highlighted by the World Health Organization (WHO). In 2022, approximately 660,000 new cases of cervical cancer ...
A British trial has discovered how to cut cervical cancer deaths by 40% in what has been described as the biggest improvement in treatment of the disease in 20 years. The 10-year study ...
A NEW treatment regime for cervical cancer cuts the risk of death by 40 per cent, according to a large-scale study. Researchers in London completed a long-term follow up of patients given a short ...